Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Test Your Knowledge Previous | All Articles This Week | Next
This article originally posted 02 December, 2011 and appeared in  Issue 602

Test Your Knowledge #602: A 70-year-old man who has type 2 diabetes, coronary artery disease, and COPD...

A 70-year-old man who has type 2 diabetes, coronary artery disease, and chronic obstructive pulmonary disease is seen for an annual physical examination.

Advertisement

He notes no health-related concerns and has no acute symptoms. He is eating healthy foods but is unable to perform regular physical activity. His blood pressure is 150/90 mm Hg, hemoglobin A1C value is 8%, LDL cholesterol level is 90 mg/dL (2.33 mmol/L), and serum electrolyte values are within normal range. His current medications are glyburide 10 mg twice daily, simvastatin 40 mg daily, and hydrochlorothiazide 25 mg daily. The physician helps the patient set a specific health goal for the next few weeks (i.e., to walk his dog at least 10 minutes 5 days a week after lunch), adds lisinopril 10 mg daily and metformin 500 mg twice daily to the patient's treatment regimen, and provides counseling and information about these new medications.

Which of the following is the most important additional step for supporting this patient?

A. Ask the patient to schedule an appointment if his health status changes

B. Schedule a follow-up appointment in 1 month

C. Refer him to a community exercise program

D. Refer him to a diabetes educator

Click here for correct answer.

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 02 December, 2011 and appeared in  Issue 602

Past five issues: Diabetes Clinical Mastery Series Issue 208 | Issue 748 | GLP-1 Special Editions September 2014 | Diabetes Clinical Mastery Series Issue 207 | Issue 747 |

2014 Most Popular Articles:

Abbott Announces Approval of Its New Unique Continuous Glucose Monitor
Posted September 05, 2014
Low Carb Beats Low Fat
Posted September 05, 2014
FDA Approves Bupropion/Naltrexone (Contrave) for Obesity by Orexigen Therapeutics
Posted September 12, 2014
Lilly's Basal Insulin Peglispro Demonstrated HbA1c Superiority against Lantus
Posted September 05, 2014
An Exclusive Interview with Al Mann, Founder and CEO, Mannkind Corp.
Posted September 15, 2014
Empagliflozin (Jardiance) SGLT-2 Inhibitor Now Available in Pharmacies
Posted August 29, 2014
Sleeve Gastrectomy Now a Common Choice for Bariatric Surgery
Posted September 12, 2014
Type 2 Diabetes Diagnosis Needs to Be Changed: Prediabetes=Diabetes
Posted September 12, 2014
Predicting Which Diabetics Will Develop Major Complications
Posted September 05, 2014
High-salt Diet and High HBA1c May Increase Cardiovascular Disease
Posted September 19, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Now that once-weekly dulaglutide has been approved, will you be prescribing it?



Search Articles On Diabetes In Control